FDA Warns Of Possible Criminal Charges Against Weight-Loss Product Firms
This article was originally published in The Tan Sheet
Executive Summary
FDA's enforcement action against 28 weight-loss products found to contain undeclared pharmaceutical ingredients drew applause from GlaxoSmithKline, marketer of alli, the only OTC drug approved for weight loss in the U.S
You may also be interested in...
Tainted Supplement Warnings Stress FDA’s Enforcement Limitations
FDA issued public notifications against 20 products marketed as weight-loss supplements containing the withdrawn Rx ingredient sibutramine.
Tainted Supplement Warnings Stress FDA’s Enforcement Limitations
FDA issued public notifications against 20 products marketed as weight-loss supplements containing the withdrawn Rx ingredient sibutramine.
Tainted Supplement Warnings Stress FDA’s Enforcement Limitations
FDA issued public notifications against 20 products marketed as weight-loss supplements containing the withdrawn Rx ingredient sibutramine.